-+ 0.00%
-+ 0.00%
-+ 0.00%

CLIMB BIO INC: FIRST PATIENTS DOSED IN BUDOPRUTUG PRISMN PHASE 2 TRIAL IN PMN, WITH INITIAL DATA EXPECTED SECOND HALF 2026

Reuters·01/08/2026 12:00:04

Please log in to view news